Latest Insider Transactions at Personalis, Inc. (PSNL)
This section provides a real-time view of insider transactions for Personalis, Inc. (PSNL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Personalis, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Personalis, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2024
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
4,834
-3.76%
|
$14,502
$3.82 P/Share
|
|
Dec 16
2024
|
Stephen Michael Moore SVP and Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,513
-2.25%
|
$4,539
$3.82 P/Share
|
|
Dec 16
2024
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
6,865
-3.95%
|
$20,595
$3.82 P/Share
|
|
Nov 18
2024
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
921
-0.71%
|
$2,763
$3.79 P/Share
|
|
Nov 18
2024
|
Stephen Michael Moore SVP and Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,693
-2.45%
|
$5,079
$3.79 P/Share
|
|
Nov 18
2024
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
1,307
-0.75%
|
$3,921
$3.79 P/Share
|
|
Nov 01
2024
|
Christopher M Hall PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
26,443
-12.93%
|
$132,215
$5.38 P/Share
|
|
Aug 16
2024
|
Tempus Ai, Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
3,500,000
+21.58%
|
$17,500,000
$5.07 P/Share
|
|
Aug 16
2024
|
Tempus Ai, Inc. > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
9,218,800
+41.67%
|
$18,437,600
$2.0 P/Share
|
|
Jul 30
2024
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
524
-0.41%
|
$1,048
$2.97 P/Share
|
|
Jul 30
2024
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
742
-0.42%
|
$1,484
$2.97 P/Share
|
|
Jun 17
2024
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
7,176
-3.92%
|
$7,176
$1.29 P/Share
|
|
Jun 17
2024
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
5,055
-3.81%
|
$5,055
$1.29 P/Share
|
|
Jun 17
2024
|
Stephen Michael Moore SVP and Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,585
-2.24%
|
$1,585
$1.29 P/Share
|
|
May 17
2024
|
Stephen Michael Moore SVP and Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,731
-2.39%
|
$1,731
$1.38 P/Share
|
|
May 17
2024
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
1,333
-0.72%
|
$1,333
$1.38 P/Share
|
|
May 17
2024
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
940
-0.7%
|
$940
$1.38 P/Share
|
|
Apr 30
2024
|
Stephen Michael Moore SVP and Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
4,523
-5.88%
|
$4,523
$1.37 P/Share
|
|
Mar 01
2024
|
Woodrow A Myers Jr |
BUY
Open market or private purchase
|
Direct |
10,000
+27.69%
|
$10,000
$1.67 P/Share
|
|
Jan 29
2024
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
526
-0.41%
|
$526
$1.37 P/Share
|
|
Jan 29
2024
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
716
-0.39%
|
$716
$1.37 P/Share
|
|
Dec 15
2023
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
6,747
-3.51%
|
$6,747
$1.47 P/Share
|
|
Dec 15
2023
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
4,708
-3.51%
|
$4,708
$1.47 P/Share
|
|
Dec 15
2023
|
Stephen Michael Moore SVP and Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,476
-1.88%
|
$1,476
$1.47 P/Share
|
|
Nov 16
2023
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
940
-0.75%
|
$940
$1.04 P/Share
|
|
Nov 16
2023
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
1,344
-0.7%
|
$1,344
$1.04 P/Share
|
|
Nov 16
2023
|
Stephen Michael Moore SVP and Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,722
-2.15%
|
$1,722
$1.04 P/Share
|
|
Nov 01
2023
|
Christopher M Hall PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
20,459
-9.09%
|
$0
$0.93 P/Share
|
|
Jul 31
2023
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
485
-0.39%
|
$970
$2.26 P/Share
|
|
Jul 31
2023
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
662
-0.34%
|
$1,324
$2.26 P/Share
|
|
Jun 16
2023
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
6,904
-3.44%
|
$13,808
$2.07 P/Share
|
|
Jun 16
2023
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
4,817
-3.7%
|
$9,634
$2.07 P/Share
|
|
Jun 16
2023
|
Stephen Michael Moore SVP and Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,509
-1.85%
|
$3,018
$2.07 P/Share
|
|
May 17
2023
|
Stephen Michael Moore SVP and Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,781
-2.14%
|
$1,781
$1.98 P/Share
|
|
May 17
2023
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
1,389
-0.69%
|
$1,389
$1.98 P/Share
|
|
May 17
2023
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
971
-0.74%
|
$971
$1.98 P/Share
|
|
May 02
2023
|
Stephen Michael Moore SVP and Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,102
-5.76%
|
$10,204
$2.29 P/Share
|
|
Mar 17
2023
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
3,945
-1.91%
|
$7,890
$2.83 P/Share
|
|
Mar 17
2023
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
1,314
-0.99%
|
$2,628
$2.83 P/Share
|
|
Jan 31
2023
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
767
-0.37%
|
$1,534
$2.2 P/Share
|
|
Jan 31
2023
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
562
-0.42%
|
$1,124
$2.2 P/Share
|
|
Dec 20
2022
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
1,750
-1.3%
|
$1,750
$1.92 P/Share
|
|
Dec 20
2022
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
3,843
-1.82%
|
$3,843
$1.92 P/Share
|
|
Dec 15
2022
|
Stephen Michael Moore SVP and Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,930
-2.13%
|
$3,860
$2.5 P/Share
|
|
Dec 15
2022
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
7,177
-5.05%
|
$14,354
$2.5 P/Share
|
|
Dec 15
2022
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
7,177
-3.29%
|
$14,354
$2.5 P/Share
|
|
Dec 14
2022
|
John Stephen West President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+1.58%
|
$20,000
$2.44 P/Share
|
|
Dec 02
2022
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
440
-0.31%
|
$880
$2.6 P/Share
|
|
Dec 02
2022
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
4,360
-1.96%
|
$8,720
$2.6 P/Share
|
|
Nov 16
2022
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
1,295
-0.9%
|
$2,590
$2.71 P/Share
|